Systematic review / meta-analysis / 2020
Approximately one third of patients with subacute combined degeneration had normal or elevated serum vitamin B12 levels.
A meta-analysis of 6 studies with 181 patients evaluated the prevalence and clinical features of subacute combined degeneration (SCD) in individuals with normal or elevated vitamin B12 levels. The pooled proportion of SCD patients with non-low serum vitamin B12 was 31.0% (95% CI: 22.5-40.8). No significant differences were observed between patients with non-low versus low B12 levels for hemoglobin (MD: -3.05, 95% CI: -12.42 to 6.33), erythrocyte mean corpuscular volume (MD: -2.37, 95% CI: -11.17 to 6.43), or functional disability rating scale on admission (MD: 0.29, 95% CI: -0.58 to 1.16).
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis
- Who was studied
- 181 patients with subacute combined degeneration across 6 studies
- What was measured
- Prevalence of normal/elevated B12, hemoglobin, MCV, functional disability
THE PAPER
Is serum vitamin B12 decrease a necessity for the diagnosis of subacute combined degeneration?: A meta-analysis.
Cao J, Xu S, Liu C. Medicine (Baltimore), 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.